GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
2,650
Funds Holding Change
+10
Funds Holding Growth
+0.4%
Value
$509B
Holding in Top 10
592
Top 10 Change
+96
Top 10 Growth
+19%
Value Growth
+7%
New
106
Increased
1,206
Reduced
1,141
Closed
74
Capital Inflow
$19.4B
Capital Outflow
$24B
Net Capital Flow
-$4.63B
Capital Flow Change
-$4.63B
Calls
$7.69B
Puts
$7.43B
Net Calls
+$266M
Put/Call Ratio
0.97